Arrhythmias & electrophysiology

Substrate Characterization and Outcomes of Ventricular Tachycardia Ablation in Amyloid Cardiomyopathy: A Multicenter Study

Circ Arrhythm ElectrophysiolPublished Retrospective observational study

Authors' conclusion

Catheter ablation can achieve control of recurrent VT/VF in more than half of patients with cardiac amyloidosis, and the reduction in VT/VF burden post-ablation may be relevant for quality of life.

Study context

Population
Patients with cardiac amyloidosis (ATTR n=16; light chain n=6) undergoing catheter ablation for ventricular tachycardia (VT)/VT/ventricular fibrillation (VF), 2013–2023mean age 68±10 years
Participants
22 patients
Outcome
Recurrent VT/VF (efficacy); major procedure-related adverse events (safety)
Follow-up
During
Methodological detailsmulticentre, international, consecutive patients
  • Multicentre
  • International
  • Consecutive patients

Main finding

As reported in the abstract

Sustained VT/VF recurrence · median follow-up 32 (14-42) months

Sustained VT/VF recurrence

9 patients

41%

Survival free from VT/VF recurrence at 36 months

56%

95% CI 36%–86%

Observational data: associations, not effects.

Further findings

OutcomeHRP value
Recurrent VT/VF by complete procedural success (multivariable)Multivariable analysis0.002P = 0.034

Complete procedural success

Complete procedural success
16 patients (73%)

Per-patient ICD therapies, 6 months before vs after ablation

Before: 6 [4-9] vs after: 0 [0-0]
P < 0.001

Substrate

Low-voltage areas in every patient, most commonly interventricular septum
n=16
Late potentials recorded
16 patients (73%)
Mappable VTs originating from interventricular septum
12 of the 26 (46%)
Inducible VTs per patient, median
1 (1-2)

Safety

Major procedure-related adverse events
4 (18%)

Original publication

Substrate Characterization and Outcomes of Ventricular Tachycardia Ablation in Amyloid Cardiomyopathy: A Multicenter Study. Circ Arrhythm Electrophysiol. Published 22 August 2024. doi:10.1161/circep.124.012788

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.